Literature DB >> 23296969

Studying microRNAs in lymphoma.

Joost Kluiver1, Izabella Slezak-Prochazka, Anke van den Berg.   

Abstract

MicroRNAs (miRNAs) play important roles in development, differentiation, homeostasis, and also in diseases such as lymphoma. This chapter describes methods to study the role of miRNAs in lymphoma. First, we describe a multiplex RT reaction followed by qPCR that can be used to determine differential expression of candidate miRNAs. Second, we provide a protocol for stable overexpression of miRNAs using lentiviral-based ectopic expression systems. Third, we describe a straightforward assay to determine whether the candidate miRNA may function as an oncogene or a tumor suppressor gene in lymphomagenesis.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23296969     DOI： 10.1007/978-1-62703-269-8_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  8 in total

1.  Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts.

Authors:  Jennie Ong; Wim Timens; Vijay Rajendran; Arjan Algra; Avrum Spira; Marc E Lenburg; Joshua D Campbell; Maarten van den Berge; Dirkje S Postma; Anke van den Berg; Joost Kluiver; Corry-Anke Brandsma
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

2.  Current Smoking is Associated with Decreased Expression of miR-335-5p in Parenchymal Lung Fibroblasts.

Authors:  Jennie Ong; Anke van den Berg; Alen Faiz; Ilse M Boudewijn; Wim Timens; Cornelis J Vermeulen; Brian G Oliver; Klaas Kok; Martijn M Terpstra; Maarten van den Berge; Corry-Anke Brandsma; Joost Kluiver
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

3.  The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.

Authors:  Julia Paczkowska; Joanna Janiszewska; Julia Bein; Markus Schneider; Kinga Bednarek; Adam Ustaszewski; Sylvia Hartmann; Martin-Leo Hansmann; Maciej Giefing
Journal:  Cells       Date:  2020-10-14       Impact factor: 6.600

4.  The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.

Authors:  Lotteke J Y M Ziel-Swier; Yichen Liu; Annika Seitz; Debora de Jong; Jasper Koerts; Bea Rutgers; Rianne Veenstra; Fazlyn R Abdul Razak; Agnieszka Dzikiewicz-Krawczyk; Anke van den Berg; Joost Kluiver
Journal:  Genes (Basel)       Date:  2022-01-25       Impact factor: 4.096

5.  Circulating miRNAs in patients with Barrett's esophagus, high-grade dysplasia and esophageal adenocarcinoma.

Authors:  Kirill Pavlov; Joost Kluiver; Coby Meijer; Wytske Boersma-van Ek; Frank A E Kruyt; Arend Karrenbeld; Jan H Kleibeuker; Frans T M Peters; Anke van den Berg
Journal:  J Gastrointest Oncol       Date:  2018-12

6.  Age-Associated Differences in MiRNA Signatures Are Restricted to CD45RO Negative T Cells and Are Associated with Changes in the Cellular Composition, Activation and Cellular Ageing.

Authors:  Nato Teteloshvili; Joost Kluiver; Kornelis S M van der Geest; Roelof Jan van der Lei; Pytrick Jellema; Graham Pawelec; Elisabeth Brouwer; Bart-Jan Kroesen; Annemieke M H Boots; Anke van den Berg
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

7.  Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.

Authors:  Izabella Slezak-Prochazka; Joost Kluiver; Debora de Jong; Katarzyna Smigielska-Czepiel; Gertrud Kortman; Melanie Winkle; Bea Rutgers; Jasper Koerts; Lydia Visser; Arjan Diepstra; Bart-Jan Kroesen; Anke van den Berg
Journal:  Oncotarget       Date:  2016-01-19

8.  Marked TGF-β-regulated miRNA expression changes in both COPD and control lung fibroblasts.

Authors:  J Ong; A Faiz; W Timens; M van den Berge; M M Terpstra; K Kok; A van den Berg; J Kluiver; C A Brandsma
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.